We’re welcoming 2023 by sharing the milestones we accomplished in 2022!

A timeline of highlights from our 36th year:
Awakn Life Sciences Partnership

Awakn Life Sciences and MAPS to Explore Partnership for Treatment of Alcohol Use Disorder in Europe
January 19
Innovation Passport

MAPS is Granted Innovation Passport in United Kingdom for MDMA as an Adjunct to Therapy for PTSD
January 25

MDMA for PTSD Study Opens in Tel Hashomer, Israel
February 3
Patient Bill of Rights

Patient Bill of Rights for Psychedelic Therapy Published
February 10
Startle Response Study

Psychopharmacology published Startle response study results
February 15

Michael Mullette Joins MAPS PBC as Chief Operating Officer
March 8
The Secret Chief

Revised Edition of The Secret Chief Revealed published
March 30
MDMA Public Domain

MAPS Places Fully Validated, Multi-Kilogram Synthesis MDMA in the Public Domain
April 5
MDMA-Assisted Therapy for PTSD

MAPS Completes Enrollment for Phase 3 Trial of MDMA-Assisted Therapy for PTSD
May 9
New York Times

The New York Times Publishes “A Balm for Psyches Scarred by War”
May 29
Board of Directors Appointment

MAPS Appoints Jeff George and Dan Grossman to MAPS PBC Board of Directors
June 7
Veterans Study

MDMA-Assisted Group Therapy for PTSD Among Veterans Study Will Proceed Following Successful Safety Negotiations
June 29
Christie’s NFT Auction

MAPS Raises Nearly $1.6 Million in Christie’s NFT Auction
June 30
How To Change Your Mind Featuring

Netflix Releases How To Change Your Mind Featuring MAPS
July 12
Psychedelic Fundamentals

MAPS Launches Psychedelic Fundamentals, an Online Education Curriculum
Jul 29
U.S. Sentencing Commission

U.S. Sentencing Commission in Reaches Quorum
August 17
Psychedelics: Chemicals, Consciousness, and Creativity

Psychedelics: Chemicals, Consciousness, and Creativity features Rick Doblin, Ph.D., MAPS Founder
September 8

MAPS Supporters Raise $101,438.51 for MAPS via AmazonSmile
September 21
Conference on Psychedelic Research 2022

MAPS Speaks at Interdisciplinary Conference on Psychedelic Research 2022
September 24
PBS Nova

PBS Nova Features MAPS in “Can Psychedelics Cure?”
October 19
MDMA-Assisted Therapy

Second MAPS-Sponsored Phase 3 Trial of MDMA-Assisted Therapy for PTSD Completed
November 17

MDMA Therapy Training

MDMA Therapy Training Program Trains 766 Therapists
December 31
Thank you to all our supporters for making 2022 an amazing year! 

Next year, don't miss Psychedelic Science 2023, the largest psychedelic gathering in history, presented by MAPS from June 19-23 in Denver, Colorado!

Help Us Deliver Global Healing

Every dollar that MAPS has raised for psychedelic research and therapy been donated by people like you. Your tax-deductible contributions are what allow MAPS to pursue the important and challenging work of psychedelic research, drug policy reform, public education, health equity, and harm reduction initiatives.

Donation Frequency
Donation Amount
< back

Contact Information

Contact information

Thanks for your contribution to MAPS!

Your tax-deductible contribution supports psychedelic science research, drug policy reform, public education, harm reduction, peer support, and our general operations.

Happy New Year!